Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.

González GM, González G, Najvar LK, Graybill JR.

J Antimicrob Chemother. 2007 Dec;60(6):1341-6. Epub 2007 Oct 12.

PMID:
17934204
2.
4.

Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.

Imai J, Singh G, Fernandez B, Clemons KV, Stevens DA.

J Antimicrob Chemother. 2005 Jul;56(1):166-71. Epub 2005 May 25.

PMID:
15917284
5.
6.

Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.

Clemons KV, Schwartz JA, Stevens DA.

Med Mycol. 2011 Nov;49(8):834-47. doi: 10.3109/13693786.2011.577822. Epub 2011 May 4.

PMID:
21539507
7.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
8.

Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.

Park DW, Sohn JW, Cheong HJ, Kim WJ, Kim MJ, Kim JH, Shin C.

BMC Infect Dis. 2006 Feb 15;6:26.

9.

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.

van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2006 Apr;57(4):732-40. Epub 2006 Feb 7.

PMID:
16464895
10.
11.

Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.

González GM, Tijerina R, Najvar LK, Bocanegra R, Rinaldi MG, Graybill JR.

Antimicrob Agents Chemother. 2004 Jun;48(6):2140-3.

12.

Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

González GM, Tijerina R, Najvar LK, Bocanegra R, Luther M, Rinaldi MG, Graybill JR.

Antimicrob Agents Chemother. 2001 Jun;45(6):1854-9.

13.

Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.

Rodríguez-Arellanes G, Taylor ML, Pérez-Torres A, Curiel-Quesada E, Vargas-Mendoza CF, Martínez-Rivera MA.

Rev Invest Clin. 2009 Jan-Feb;61(1):4-10.

PMID:
19507469
14.

Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.

Clemons KV, Schwartz JA, Stevens DA.

Antimicrob Agents Chemother. 2012 Aug;56(8):4439-49. doi: 10.1128/AAC.06015-11. Epub 2012 Jun 11.

15.

Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.

Sionov E, Mendlovic S, Segal E.

J Infect. 2006 Aug;53(2):131-9. Epub 2005 Dec 19.

PMID:
16360214
16.

Amphotericin B and coccidioidomycosis.

Johnson RH, Einstein HE.

Ann N Y Acad Sci. 2007 Sep;1111:434-41. Epub 2007 May 18. Review.

PMID:
17513463
17.

Effects of amphotericin B and caspofungin on histamine expression.

Cleary JD, Schwartz M, Rogers PD, de Mestral J, Chapman SW.

Pharmacotherapy. 2003 Aug;23(8):966-73.

PMID:
12921242
18.

Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis.

Takazono T, Izumikawa K, Mihara T, Kosai K, Saijo T, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S.

Antimicrob Agents Chemother. 2009 Aug;53(8):3508-10. doi: 10.1128/AAC.00285-09. Epub 2009 Jun 15.

19.

Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.

Nagasaki Y, Eriguchi Y, Uchida Y, Miyake N, Maehara Y, Kadowaki M, Harada M, Akashi K, Shimono N.

J Antimicrob Chemother. 2009 Aug;64(2):379-82. doi: 10.1093/jac/dkp175. Epub 2009 May 22.

PMID:
19465436
20.

Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.

Levy ER, McCarty JM, Shane AL, Weintrub PS.

Clin Infect Dis. 2013 Jun;56(11):1573-8. doi: 10.1093/cid/cit113. Epub 2013 Mar 5.

PMID:
23463636

Supplemental Content

Support Center